ThyCa: Thyroid Cancer Survivors' Association, Inc.
ThyCa: Thyroid Cancer Survivors' Association, Inc. is a non-profit 501(c)(3) organization of thyroid cancer survivors, family members, and health care professionals. We are dedicated to support, education, and communication for thyroid cancer survivors, their families and friends. We also sponsor Thyroid Cancer Awareness Month, year-round awareness activities, and thyroid cancer research fundraising and research grants.
Visit us at www.thyca.org.
352 Genetic/Molecular Testing: What it tells us and more importantly what it doesn’t!
351 Telehealth medicine: Not available across state lines
344 Exploring the mixed messages of the "good cancer"
343 Understanding tumor complexity in medullary thyroid cancer
342 Being your own patient advocate. Do I have the right medical team for my situation?
341 Ask a doctor your questions about papillary and follicular thyroid cancer
334 An individualized approach to thyroid hormone replacement for thyroid cancer patients
333 Long term management of medullary thyroid cancer after surgery.
332 Extent of surgery for low-risk thyroid cancer. In the spirit "doing less is more"
331 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets
324 Overview and discussion about thyroid cancer, fertility, and pregnancy
323 Re-engineering the immune system to treat cancer
322 Management of initial, persistent, or recurrent thyroid cancer
321 Долгосрочное наблюдение папиллярного и фолликулярного рака щитовидной железы после операции и...
301 Living with thyroid cancer
275 Considerations in treatment of advanced pediatric thyroid cancer, including clinical trials
274 Modeling center of excellence practices to improve the care of patients with thyroid cancer
273 Neoadjuvant therapy followed by surgery in all types of thyroid cancer
272 Immunotherapy and combinations with targeted therapy in follicular cell-derived thyroid cancers
266 How we approach thyroid cancer management in pediatric thyroid cancer
264 Update on treatment of anaplastic thyroid cancer
263 CAR T-cell therapy for medullary thyroid cancer: The personal story and the science
262 Pre-op evaluation of thyroid cancer including the importance of having an accurate ultrasound
261 Extent of surgery for primary thyroid cancer and recurrent thyroid cancer
256 Haga sus preguntas a el médico en español
254 Discussion about the low-iodine diet
252 Systemic therapies in adv. radioactive iodine refractory (non-avid, RAI-R) diff. thyroid cancer
245 Am I a candidate for a non-surgical treatment option? A discussion about thermal ablation
244 Применение Тирогена® в сравнении с отменой Т4
243 Update in medullary thyroid cancer clinical trials